Researching on morphological characteristics of lesions and role of new immunohistochemistry markers (Beta-catenin, Glutamin Synthetase, L-FPBP, SAA..) in diagnosis of hepatocellular adenoma, classifying HCC into subtypes support clinicians make a prognosis, give treatment and follow-up.